Cargando…
T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell
Objective: To test the safety and efficacy of a T cell therapy de novo targeting HLA-A02 restricted HIV antigen epitopes. Design: This was a prospective open label clinical trial, which enrolled 28 HIV+ participants and 24 of them finished the trial. The study was publicly registered at Chinese Clin...
Autores principales: | Liu, Sai, Sun, Jianping, Li, Zhen, Qin, Ling, Liu, Guihai, Li, Kang, Wu, Hao, Dong, Tao, Zhang, Yonghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435000/ https://www.ncbi.nlm.nih.gov/pubmed/30941124 http://dx.doi.org/10.3389/fimmu.2019.00437 |
Ejemplares similares
-
Cancer testis antigen Cyclin A1 harbors several HLA-A*02:01-restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2020) -
Correction to: Cancer testis antigen Cyclin A1 harbors several HLA‑A*02:01‑restricted T cell epitopes, which are presented and recognized in vivo
por: Teck, Anja Tatjana, et al.
Publicado: (2021) -
Characterization of amino acid residues of T-cell receptors interacting with HLA-A*02-restricted antigen peptides
por: Zhu, Ying, et al.
Publicado: (2021) -
Understanding CD8(+) T-cell responses toward the native and alternate HLA-A*02:01-restricted WT1 epitope
por: Nguyen, Thi HO, et al.
Publicado: (2017) -
Design and synthesis of HLA-A*02-restricted Hantaan virus multiple-antigenic peptide for CD8(+) T cells
por: Ma, Yan, et al.
Publicado: (2020)